Annual Reports in Medicinal Chemistry, Volume 67 presents authoritative and forward-looking reviews that capture current advances in medicinal chemistry, with a strong emphasis on molecular conjugates, hybrid therapeutics, and precision drug design. Contributions from leading international researchers examine emerging strategies for antiviral, antifungal, and antimicrobial drug development, including small-molecule conjugates, aptamer-RNA platforms, terpene-derived hybrids, and intracellular targeting approaches.
The volume highlights how chemical innovation is being leveraged to address drug resistance, emerging viral threats, and unmet clinical needs, while also reflecting broader methodological advances in conjugate design, carrier systems, and structure-activity relationships. As with previous volumes in the series, ARMC 67 serves as both a critical reference and a forward-looking guide for medicinal chemists in academia and industry.
The volume highlights how chemical innovation is being leveraged to address drug resistance, emerging viral threats, and unmet clinical needs, while also reflecting broader methodological advances in conjugate design, carrier systems, and structure-activity relationships. As with previous volumes in the series, ARMC 67 serves as both a critical reference and a forward-looking guide for medicinal chemists in academia and industry.
